Radio and PodcastRadio and PodcastLive Radio & Podcasts
Relacorilant artwork
Science & Medicine

Relacorilant

OncoPharm by OncoPharmPod

Apr 9, 202600:15:13Science & Medicine

Discussing the new nab-paclitaxel adjunctive medication, relacorilant, for ovarian cancer. As a glucoCORticoid receptor antagonist, it is hard to pronounce. Also, a 10-year follow-up study of ibrutinib provides big pictu...

About This Episode

Relacorilant is an episode from OncoPharm by OncoPharmPod. Discussing the new nab-paclitaxel adjunctive medication, relacorilant, for ovarian cancer. As a glucoCORticoid receptor antagonist, it is hard to pronounce. Also, a 10-year follow-u...

Podcast

This episode belongs to OncoPharm.

Listen Online

Use the player on this page to stream the episode online.

Episode Details

Published Apr 9, 2026, 00:15:13 long, audio available.

Questions About This Episode

What is Relacorilant about?

Discussing the new nab-paclitaxel adjunctive medication, relacorilant, for ovarian cancer. As a glucoCORticoid receptor antagonist, it is hard to pronounce. Also, a 10-year follow-up study of ibrutinib provides big picture insight on the impact of the BTKi era in CLL. Link: Check out the Oncology Insights Newsletter:

Where can I listen to Relacorilant?

You can listen to Relacorilant online on Radio and Podcast. Open the player on this page to stream the available audio.

Which podcast is Relacorilant from?

Relacorilant is an episode from OncoPharm by OncoPharmPod.

How long is this episode?

This episode is 00:15:13 long.

When was this episode published?

This episode was published on Apr 9, 2026.

Can I save Relacorilant for later?

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Are there related episodes from OncoPharm?

Yes. This page shows related episodes from OncoPharm when more episodes are available from the podcast feed.